Advertisement

Topics

Aziyo Presents Positive Initial Data from Clinical Study of Biologic Extracellular Matrix Scaffold for Femoral Arterial Reconstruction

09:30 EST 15 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Aziyo Biologics, Inc., a fully integrated regenerative medicine company, today announced positive results from PERFORM, a prospective, post-market study conducted in patients undergoing femoral arterial reconstruction usi...

Other Sources for this Article

Aziyo Biologics, Inc.
Erica Elchin, 510-730-7896
PR@aziyo.com

NEXT ARTICLE

More From BioPortfolio on "Aziyo Presents Positive Initial Data from Clinical Study of Biologic Extracellular Matrix Scaffold for Femoral Arterial Reconstruction"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...